SEC Form 4 · accession 0001415889-15-003941
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Srdjan R. Stankovic
Officer — EXECUTIVE VICE PRESIDENT
Period of report
Nov 25, 2015
Accepted (ET)
Nov 30, 2015 · 7:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $38.28 | Nov 25, 2015 | A | 250,000 | A | — | Nov 24, 2025 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F125% of the shares subject to the Stock Option vest and become exercisable on the first anniversary of the date of grant. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.